Your browser doesn't support javascript.
loading
Purification of mumps virus particles of high viability.
Chen, Huosheng; Ngo, Laurie; Petrovskaya, Svetlana; Gao, Yamei; Laassri, Majid; Rubin, Steven.
Affiliation
  • Chen H; Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.
  • Ngo L; Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.
  • Petrovskaya S; Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.
  • Gao Y; Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.
  • Laassri M; Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.
  • Rubin S; Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States. Electronic address: steven.rubin@fda.hhs.gov.
J Virol Methods ; 233: 6-9, 2016 Jul.
Article in En | MEDLINE | ID: mdl-26992653
Mumps is a highly infectious viral disease of humans with a wide array of clinical manifestations ranging from painful swelling of the salivary glands to meningitis and encephalitis. Despite the clinical importance of mumps virus, most of what is known of its biological properties comes from studies using supernatants from virus infected cell cultures, which contain substantial levels of host cell derived debris and biologically active substances such as cytokines, transcription factors and secreted virus proteins. These contaminants complicate interpretation of studies of virus replication, virus-host interactions and in vivo virulence. Here we describe a protocol for concentration of the virus from cell culture supernatants followed by gradient purification, resulting in attainment of high titer live virus of high purity.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virion / Microbial Viability / Mumps virus Type of study: Guideline Limits: Humans Language: En Journal: J Virol Methods Year: 2016 Document type: Article Affiliation country: United States Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virion / Microbial Viability / Mumps virus Type of study: Guideline Limits: Humans Language: En Journal: J Virol Methods Year: 2016 Document type: Article Affiliation country: United States Country of publication: Netherlands